Loading stock data…
NRC Health (NRC)
$21.19-0.34 (-1.58%)
Market ClosedLast close Sep 8
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NRC Health in the Healthcare sector is trading at $21.19 with a market capitalization of $469M. Wall Street consensus targets $26.00 (1 analysts), implying a +22.7% move over the next 12 months. The stock is currently near its 52-week high of $23.68, remaining 15.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +22.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $35.39M↑ | $34.80M↓ | $35.19M↑ | $34.61M↑ | $34.04M |
| Gross Profit | $21.83M↑ | $21.16M↓ | $21.26M↓ | $22.20M↑ | $21.06M |
| Operating Income | -$3.24M↓ | $5.57M↑ | $4.67M↓ | $7.74M↑ | $1.59M |
| Net Income | -$3.28M↓ | $3.22M↑ | $1.80M↓ | $4.12M↑ | -$106,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$468.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
88.29
Beta
Defensive asset. Lower volatility than the S&P 500.
0.38
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.83%
ROE
Elite ROE. Management converts capital into profit efficiently.
89.46%
Volume
Today's trading volume
144,566
Recent News
Record Backlog Powers NRC Health’s (NRC) Upward Potential
Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with results improving 20%, bringing year-to-date returns to +19%. While performance trailed the Russell 2000 and iShares US MicroCap ETF, it remained well ahead of the […]
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty
NRC Health (NRC) reports an 11% increase in Total Recurring Contract Value, while navigating challenges from market shifts and strategic investments.
National Research Q2 Earnings Call Highlights
National Research (NASDAQ:NRC), operating as NRC Health, reported second-quarter results marked by 11% year-over-year growth in total recurring contract value, while management said investments in implementation, customer success and product development supported a large customer deployment and futu
There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings
Soft earnings didn't appear to concern NRC Health's ( NASDAQ:NRC ) shareholders over the last week. We think that the...